Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

NCT05674305 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

366

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Radiotherapy
DRUG: Cisplatin

Sponsor

Fudan University